Healthcare advertising compliance in India.

Healthcare advertising in India operates under more constraint than almost any other vertical. Four regulatory frameworks govern what a hospital, clinic, or practitioner can say to the public — and they overlap. A campaign that satisfies one can still violate another. A social media post that reads as informational can be construed as advertising. A doctor’s personal branding can cross into unethical self-promotion under the medical ethics code.

The four frameworks this guide covers:

• The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 — central legislation restricting public advertising of treatments for certain diseases.
• The Medical Council of India / National Medical Commission Code of Ethics — professional code governing how registered medical practitioners may advertise themselves and their practice.
• The Telangana State Medical Council guidelines — state-level layer on hospital registration, disclosure, and clinic advertising for practitioners in Telangana.
• NABH accreditation usage standards — how the accreditation mark and claims may be used in marketing.

None of these are new. The DMR Act is from 1954 — older than India’s internet. The MCI Code dates to 2002 (with NMC superseding the MCI in 2020 but the ethics regulations carrying forward). What is new is the surface area: digital ads, social posts, hospital websites, WhatsApp broadcasts, doctor LinkedIn profiles, lead magnets, paid retargeting. Each of these is now reachable to regulators, and each can be cited as evidence in an enforcement action.

The penalties matter. Statutory fines and imprisonment under the DMR Act. State Medical Council action against the registered practitioner. Ad-platform suspension by Google and Meta. Most of all: credibility loss with patients, who increasingly recognize and flag non-compliant marketing.

This guide is a working reference, written for hospital operators, practice administrators, and the marketing teams supporting them. It is not legal advice — see the disclaimer.

The Medical Council of India was dissolved in 2020 and replaced by the National Medical Commission (NMC). The MCI Code of Ethics Regulations, 2002 remain operative, with NMC having issued additional regulations since. Together they govern how a registered medical practitioner may advertise themselves and their practice. This is distinct from the DMR Act, which restricts what can be advertised — the ethics code governs who can advertise it and how.

Who the code applies to

The code applies to every registered medical practitioner. Hospitals and clinics aren’t directly covered as institutions — but the practitioners on staff are, and any marketing that uses a practitioner’s name, credentials, or image puts that practitioner’s registration on the line.

What the code restricts

Chapter 6 of the 2002 regulations addresses unethical acts in advertisement, and Chapter 7 covers misconduct. The operative restrictions for marketing teams:

• Self-aggrandizing language: claims of being the “best,” “top,” “leading,” “most experienced,” or otherwise asserting superiority over other practitioners are restricted.
• Comparative claims: explicit or implicit comparison with other practitioners or institutions is restricted. This rules out language like “higher success rate than the city average,” “better outcomes than nearby hospitals,” or scoring graphics that imply rank.
• Inflated or unrecognized qualifications: a practitioner may surface only the degrees and qualifications recognized by the relevant medical council. Foreign degrees that aren’t equivalent-recognized, honorary credentials, and membership of unaccredited bodies cannot be advertised as qualifications.
• Testimonials of efficacy: patient testimonials that endorse specific outcomes or imply guaranteed success are restricted. Honest reviews on third-party platforms (Google Business Profile) that aren’t solicited as outcome endorsements occupy a distinct, more permissive position.
• Before-and-after imagery: cosmetic and aesthetic procedures depend on before-and-after for marketing efficacy, but the regulations require honest representation, patient consent, and disclosure that individual results vary. Misleading or selectively- edited imagery is grounds for action.
• Solicitation of patients through advertisement: direct solicitation of patients in a manner unbecoming of the medical profession is restricted. The line between informing the public and soliciting individual patients is interpreted contextually.

What is permitted

• Formal announcement of starting practice, change of address, return from leave, taking partners, association with hospitals — provided the announcement is dignified and factual.
• Educational contentin newspapers, magazines, and digital media — provided it stays educational and doesn’t promote a specific practitioner’s practice.
• Hospital advertisingby the institution as an institution — provided the practitioners associated aren’t individually promoted in ways the code restricts.
• Information disclosure — qualifications, affiliations, areas of practice, OPD timings, hospital association — when presented as factual information rather than promotional superiority claims.

Social media specifically

The NMC has, since 2022, issued specific guidance on social media use by registered medical practitioners. Key points:

• Doctors can have professional social media presences. Educational content, public-health communication, and verified clinical commentary are permitted.
• Self-promotion that crosses into advertising — comparative claims, success-outcome posts, treatment-cure language — falls under the same restrictions as offline advertising.
• Patient confidentiality is paramount. Sharing patient cases on social media without explicit consent (and even with consent in many contexts) is unethical.
• Sponsorship disclosures matter. Endorsing products in exchange for consideration without disclosure is misconduct.

Penalties

The State Medical Council can suspend or cancel a practitioner’s registration. Lesser penalties include warnings, conditional registration, and removal from the speciality register. Hospitals associated with non-compliant practitioner advertising can suffer reputational and operational impact even when the institution itself isn’t the primary defendant.

The National Accreditation Board for Hospitals & Healthcare Providers (NABH) is a constituent board of the Quality Council of India. NABH accredits hospital quality systems against published standards — it does not endorse specific treatments, practitioners, or outcomes. How the accreditation is used in marketing materially affects both credibility and risk.

What NABH actually accredits

NABH’s standards cover hospital operations: patient access, patient rights, care of patients, medication management, infection control, governance, human resource management, information management. Accreditation is awarded at the facility level (the hospital as a whole) and at the program level (specific accreditation for emergency departments, dental facilities, eye care, blood banks, etc.).

Accreditation is time-limited. NABH facility accreditation is typically awarded for three years, with periodic surveillance audits and re-accreditation. The status can lapse, be suspended, or be withdrawn.

Permitted marketing usage

• Stating that the hospital is NABH-accredited, with the accreditation number and effective period where appropriate.
• Using the NABH logo in accordance with NABH’s own brand guidelines — typically with accompanying accreditation number and appropriate sizing and placement.
• Referencing specific NABH-accredited departments or programs where that program-level accreditation exists.
• Educating patients on what NABH accreditation means as a quality signal — provided the educational content stays accurate.

Common impermissible usage

• Treatment endorsement implication: “NABH-approved treatment for [X]” mis-states what NABH does. NABH accredits the hospital’s quality systems; it does not certify the efficacy or safety of specific treatments.
• Outcome implication: language that ties NABH accreditation to specific clinical outcomes (“NABH-accredited means higher success rate”) crosses into misleading territory.
• Practitioner-level claims: NABH doesn’t accredit individual practitioners. “NABH-accredited surgeon” is meaningless and risks misrepresentation action.
• Lapsed accreditation: continuing to display NABH accreditation after it has lapsed or been suspended is misleading and actionable.
• Wrong program-level claim: claiming department-level NABH accreditation the hospital doesn’t have. Facility-level accreditation doesn’t automatically extend to program-level (and vice versa).

Operational discipline

For hospitals where NABH accreditation is a meaningful trust signal — particularly in cardiology, oncology, transplant, and other high-acuity services — the marketing surface should:

• Surface the accreditation status accurately, with number and effective period available on the hospital’s website.
• Refresh marketing materials when accreditation is renewed, suspended, or lapsed — at least quarterly review of all surfaces is a reasonable cadence.
• Avoid implying NABH-related claims that go beyond what the accreditation actually certifies.
• Where program-level accreditation exists for specific departments (e.g., NABH Nursing Excellence), make program-level claims at the department level only.